HIV prevention and treatment strategies can help address the overdose crisis

Preventive Medicine

Volumn 80, Issue , 2015, Pages 37-40

  Walley, Alexander Y ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV; Naloxone; Opioids; Overdose

Indexed keywords

ACCIDENTAL INJURY; COOPERATION; DRUG INTOXICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; NOTE; OPIATE ADDICTION; PATIENT CARE; PATIENT COUNSELING; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SUBSTANCE ABUSE; DRUG OVERDOSE; HIV INFECTIONS; OPIOID-RELATED DISORDERS; UNITED STATES;

NALOXONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ANALGESICS, OPIOID; DRUG OVERDOSE; HIV INFECTIONS; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; UNITED STATES;

EID: 84942816483     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2015.04.004     Document Type: Note

References (37)

1. Albert S., Brason F.W., Sanford C.K., Dasgupta N., Graham J., Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011, 12(Suppl. 2):S77-S85. 10.1111/j.1526-4637.2011.01128.x.
2. Aspinall E.J., Nambiar D., Goldberg D.J., et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int. J. Epidemiol. 2014, 43(1):235-248. 10.1093/ije/dyt243.
3. Baggett T.P., Hwang S.W., O'Connell J.J., et al. Mortality among homeless adults in Boston. JAMA Intern. Med. 2013, 173(3):189-195. 10.1001/jamainternmed.2013.1604.
4. Broadhead R.S., Heckathorn D.D., Weakliem D.L., et al. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998, 113(Suppl. 1):42-57.
5. Broz D., Wejnert C., Pham H.T., et al. Behavioral Surveillance System Study Group. HIV infection and risk, prevention, and testing behaviors among injecting drug users-National HIV Behavioral Surveillance System, 20 U.S. cities, 2009. MMWR Surveill. Summ. 2014, 63(6):1-51. (Jul 4).
6. Centers for Disease Control and Prevention, 2012. HIV Surveillance Report, vol. 24. http://www.cdc.gov/hiv/pdf/statistics_2012_HIV_Surveillance:Report_vol_24.pdf. Published November 2014. Accessed January 1, 2015.
7. Centers for Disease Control and Prevention Web-based Injury Statistics Query and Reporting System (WISQARS) [online] Available from URL, (Accessed March 26, 2015). http://www.cdc.gov/injury/wisqars/fatal.html%20and%20http://www.cdc.gov/injury/wisqars/pdf/leading_causes_of_injury_deaths_highlighting_unintentional_injury_2012-a.pdf.
8. Clausen T., Waal H., Thoresen M., Gossop M. Mortality Among Opiate Users: Opioid Maintenance Therapy, Age and Causes of Death. Addiction 2009, 104(8):1356-1362. 10.1111/j.1360-0443.2009.02570.x.
9. Cohen M.S., Chen Y.Q., McCauley M., Gamble T., Hosseinipour M.C., Kumarasamy N., Hakim J.G., Kumwenda J., Grinsztejn B., Pilotto J.H., Godbole S.V., Mehendale S., Chariyalertsak S., Santos B.R., Mayer K.H., Hoffman I.F., Eshleman S.H., Piwowar-Manning E., Wang L., Makhema J., Mills L.A., de Bruyn G., Sanne I., Eron J., Gallant J., Havlir D., Swindells S., Ribaudo H., Elharrar V., Burns D., Taha T.E., Nielsen-Saines K., Celentano D., Essex M., Fleming T.R. HPTN 052 Study Team. Prevention of HIV-1 Infection with Early Antiretroviral Therapy. N. Engl. J. Med. 2011, 365(6):493-505. 10.1056/NEJMoa1105243.
10. Committee on Crossing the Quality Chasm Adaptation to Mental Health and Addictive Disorders. Improving the Quality of Health Care for Mental and Substance-Use Conditions: Quality Chasm Series 2006, National Academies Press, Washington, DC.
11. Davis C.S., Ruiz S., Glynn P., Picariello G., Walley A.Y. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. Am. J. Public Health 2014, 104(8):e7-e9. 10.2105/AJPH.2014.302062.
12. Doe-Simkins M., Quinn E., Xuan Z., et al. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health 2014, 14:297. 10.1186/1471-2458-14-297.
13. Inocencio T.J., Carroll N.V., Read E.J., Holdford D.A. The economic burden of opioid-related poisoning in the United States. Pain Med. 2013, 14(10):1534-1547. 10.1111/pme.12183.
14. Gilbert L., Primbetova S., Nikitin D., et al. Redressing the epidemics of opioid overdose and HIV among people who inject drugs in Central Asia: the need for a syndemic approach. Drug Alcohol Depend. 2013, 132(Suppl. 1):S56-S60. 10.1016/j.drugalcdep.2013.07.017.
15. Green T.C., McGowan S.K., Yokell M.A., Pouget E.R., Rich J.D. HIV infection and risk of overdose: a systematic review and meta-analysis. AIDS 2012, 26(4):403-417. 10.1097/QAD.0b013e32834f19b6.
16. Guydish J., Bucardo J., Young M., Woods W., Grinstead O., Clark W. Evaluating needle exchange: are there negative effects?. AIDS. 1993, 7(6):871-876.
17. Kohli R., Lo Y., Howard A.A., Buono D., FLoris-Moore M., Rs Klein, Schoenbaum E.E. Mortality in an Urban Cohort of HIV-infected and At-risk Drug Users in the Era of Highly Active Antiretroviral Therapy. Clin. Infect. Dis. 2005, 41:864-872.
18. MacArthur G.J., van Velzen E., Palmateer N., Kimber J., Pharris A., Hope V., Taylor A., Roy K., Aspinall E., Goldberg D., Rhodes T., Hedrich D., Salminen M., Hickman M., Hutchinson S.J. Interventions to Prevent HIV and Hepatitis C in People Who Inject Drugs: A Review of Reviews to Assess Evidence of Effectiveness. Int. J. Drug Policy 2014, 25(1):34-52. 10.1016/j.drugpo.2013.07.001.
19. Marshall B.D., Milloy M.J., Wood E., Montaner J.S., Kerr T. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet 2011, 377(9775):1429-1437. 10.1016/S0140-6736(10)62353-7.
20. Mathers B.M., Degenhardt L., Bucello C., Lemon J., Wiessing L., Hickman M. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ 2013 Feb 1, 91(2):102-123. doi: 10.2471/BLT.12.108282.
21. Meyer J.P., Althoff A.L., Altice F.L. Optimizing Care for HIV-infected People Who Use Drugs: Evidence-Based Approaches to Overcoming Healthcare Disparities. Clin. Infect. Dis. 2013, 57(9):1309-1317. 10.1093/cid/cit427.
22. Montaner J.S., Lima V.D., Harrigan P.R., et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting. PLoS One 2014, 9(2):e87872. 10.1371/journal.pone.0087872.
23. Muga R., Langohr K., Tor J., et al. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs. Clin. Infect. Dis. 2007, 45(3):370-376.
24. National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention, Centers for Disease Control and Prevention Prescription painkiller overdoses in the US. CDC Vital Signs 2011, (Accessed March 28, 2015 at http://www.cdc.gov/vitalsigns/pdf/2011-11-vitalsigns.pdf).
25. Nosyk B., Audoin B., Beyrer C., Cahn P., Granich R., Havlir D., Katabira E., Lange J., Lima V.D., Patterson T., Strathdee S.A., Williams B., Montaner J. Examining the Evidence on the Causal Effect of HAART on Transmission of HIV Using the Bradford Hill Criteria. AIDS 2013, 27(7):1159-1165. 10.1097/QAD.0b013e32835f1d68.
26. Potier C., Laprévote V., Dubois-Arber F., Cottencin O., Rolland B. Supervised Injection Services: What Has Been Demonstrated? A Systematic Literature Review. Drug Alcohol Depend. 2014, 145C:48-68. 10.1016/j.drugalcdep.2014.10.012.
27. Reece R., Dugdale C., Touzard-Romo F., Noska A., Flanigan T., Rich J.D. Care at the crossroads: navigating the HIV, HCV, and substance abuse syndemic. Fed. Pract. 2014, 31:37S-40S.
28. Schwartz R.P., Gryczynski J., O'Grady K.E., et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. Am. J. Public Health 2013, 103(5):917-922. (May, Epub 2013 Mar 14). 10.2105/AJPH.2012.301049.
29. Schwarz R., Zelenev A., Bruce R.D., Altice F.L. Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. J. Subst. Abus. Treat. 2012, 43:451-457. 10.1016/j.jsat.2012.03.008.
30. Stein M.R., Soloway I.J., Jefferson K.S., Roose R.J., Arnsten J.H., Litwin A.H. Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program. J. Subst. Abus. Treat. 2012, 43:424-432. 10.1016/j.jsat.2012.08.007.
31. Sorensen J.L., Haug N.A., Larios S., et al. Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance. J. Subst. Abus. Treat. 2012, 43:418-423. 10.1016/j.jsat.2012.08.014.
32. Substance Abuse and Mental Health Services Administration SAMHSA Opioid Overdose Prevention Toolkit. HHS Publication No. (SMA) 14-4742 2014, Substance Abuse and Mental Health Services Administration, Rockville, MD.
33. Van Boekel L.C., Brouwers E.P., van Weeghal J., Garretsen H.F. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: a systematic review. Drug Alcohol Depend. 2013, 131:23-35. 10.1016/j.drugalcdep.2013.02.018.
34. Vlahov D., Galai N., Safaeian M., Galea S., Kirk G.D., Lucas G.M., Sterling T.R. Effectiveness of Highly Active Antiretroviral Therapy Among Injection Drug Users with Late-stage Human Immunodeficiency Virus Infection. Am. J. Epidemiol. 2005, 161(11):999-1012.
35. Wang C., Vlahov D., Galai N., Bareta J., Strathdee S.A., Nelson K.E., Sterling T.R. Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J. Infect. Dis. 2004, 190:1046-1054.
36. Wakeman S.E., Green T.C., Rich J.D. From documenting death to comprehensive care: applying lessons from the HIV/AIDS epidemic to addiction. Am. J. Med. 2014, 127(6):465-466. (Jun). 10.1016/j.amjmed.2013.12.018.
37. Walley A.Y., Xuan Z., Hackman H.H., et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ 2013, 346:f174. 10.1136/bmj.f174.